{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["MD-2", "TLR4", "enantioselective modulation", "morphine analgesia", "norbinaltorphimine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31162938", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "06", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1096/fj.201900173RRR"], "Journal": {"ISSN": "1530-6860", "JournalIssue": {"Volume": "33", "Issue": "8", "PubDate": {"Year": "2019", "Month": "Aug"}}, "Title": "FASEB journal : official publication of the Federation of American Societies for Experimental Biology", "ISOAbbreviation": "FASEB J"}, "ArticleTitle": "Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling.", "Pagination": {"StartPage": "9577", "EndPage": "9587", "MedlinePgn": "9577-9587"}, "Abstract": {"AbstractText": ["Deregulation of innate immune TLR4 signaling contributes to various diseases including neuropathic pain and drug addiction. Naltrexone is one of the rare TLR4 antagonists with good blood-brain barrier permeability and showing no stereoselectivity for TLR4. By linking 2 naltrexone units through a rigid pyrrole spacer, the bivalent ligand norbinaltorphimine was formed. Interestingly, (+)-norbinaltorphimine [(+)-1] showed \u223c25 times better TLR4 antagonist activity than naltrexone in microglial BV-2 cell line, whereas (-)-norbinaltorphimine [(-)-1] lost TLR4 activity. The enantioselectivity of norbinaltorphimine was further confirmed in primary microglia, astrocytes, and macrophages. The activities of meso isomer of norbinaltorphimine and the molecular dynamic simulation results demonstrate that the stereochemistry of (+)-1 is derived from the (+)-naltrexone pharmacophore. Moreover, (+)-1 significantly increased and prolonged morphine analgesia <i>in vivo</i>. The efficacy of (+)-1 is long lasting. This is the first report showing enantioselective modulation of the innate immune TLR signaling.-Zhang, X., Peng, Y., Grace, P. M., Metcalf, M. D., Kwilasz, A. J., Wang, Y., Zhang, T., Wu, S., Selfridge, B. R., Portoghese, P. S., Rice, K. C., Watkins, L. R., Hutchinson, M. R., Wang, X. Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Zhang", "ForeName": "Xiaozheng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Molecular Biology of Special Economic Animals, Institute of Special Wild Economic Animals and Plants, Chinese Academy of Agricultural Sciences, Changchun, China."}], "LastName": "Peng", "ForeName": "Yinghua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychology and Neuroscience, Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado, USA."}], "LastName": "Grace", "ForeName": "Peter M", "Initials": "PM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA."}], "LastName": "Metcalf", "ForeName": "Matthew D", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychology and Neuroscience, Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado, USA."}], "LastName": "Kwilasz", "ForeName": "Andrew J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China."}], "LastName": "Wang", "ForeName": "Yibo", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China."}], "LastName": "Zhang", "ForeName": "Tianshu", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Siru", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA."}], "LastName": "Selfridge", "ForeName": "Brandon R", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA."}], "LastName": "Portoghese", "ForeName": "Philip S", "Initials": "PS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA."}], "LastName": "Rice", "ForeName": "Kenner C", "Initials": "KC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Psychology and Neuroscience, Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado, USA."}], "LastName": "Watkins", "ForeName": "Linda R", "Initials": "LR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Physiology, Adelaide Medical School and Australian Research Council (ARC) Centre of Excellence for Nanoscale Biophotonics, University of Adelaide, South Australia, Australia."}], "LastName": "Hutchinson", "ForeName": "Mark R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, Beijing, China."}, {"Identifier": [], "Affiliation": "Department of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, China."}], "LastName": "Wang", "ForeName": "Xiaohui", "Initials": "X"}], "GrantList": [{"GrantID": "R01 DE017782", "Acronym": "DE", "Agency": "NIDCR NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "FASEB J", "NlmUniqueID": "8804484", "ISSNLinking": "0892-6638"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Ly96 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Lymphocyte Antigen 96"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "36OOQ86QM1", "NameOfSubstance": "norbinaltorphimine"}, {"RegistryNumber": "5S6W795CQM", "NameOfSubstance": "Naltrexone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Astrocytes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lymphocyte Antigen 96"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Microglia"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Naltrexone"}, {"QualifierName": [], "DescriptorName": "Protein Structure, Secondary"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Toll-Like Receptor 4"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}], "CoiStatement": "The authors thank the Drug Supply Program of National Institute of Drug Abuse (Bethesda, MD, USA) for providing (\u2212)-norbinaltorphimine. The authors also thank the Network and Coumputing Center, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, National Supercomputer Center of China in Guangzhou and the Computing Center of Jilin Province for the supply of computational resources. This work was supported by the National Key Research and Development Program of China (2016YFC0800907), the National Natural Science Foundation of China (21850410455, 21750110432, 21877106), the 100 Talents Program of Chinese Academy of Sciences, Young Talents Program of Chinese Academy of Agricultural Sciences, Central Public-interest Scientific Institution Basal Research Fund (NO.1610342016013), Natural Science Foundation of Jilin Province (20180101021JC), Open Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (Grant No. KF-GN-201601), and U.S. National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research Grant R01 DE017782 (to L.R.W.). The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Takeuchi O., Akira S. (2010) Pattern recognition receptors and inflammation. Cell 140, 805\u2013820", "ArticleIdList": ["20303872"]}, {"Citation": "Yang H., Hreggvidsdottir H. S., Palmblad K., Wang H., Ochani M., Li J., Lu B., Chavan S., Rosas-Ballina M., Al-Abed Y., Akira S., Bierhaus A., Erlandsson-Harris H., Andersson U., Tracey K. J. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. USA 107, 11942\u201311947", "ArticleIdList": ["PMC2900689", "20547845"]}, {"Citation": "Wang X., Smith C., Yin H. (2013) Targeting Toll-like receptors with small molecule agents. Chem. Soc. Rev. 42, 4859\u20134866", "ArticleIdList": ["PMC3665707", "23503527"]}, {"Citation": "Wang X., Loram L. C., Ramos K., de Jesus A. J., Thomas J., Cheng K., Reddy A., Somogyi A. A., Hutchinson M. R., Watkins L. R., Yin H. (2012) Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc. Natl. Acad. Sci. USA 109, 6325\u20136330", "ArticleIdList": ["PMC3341002", "22474354"]}, {"Citation": "Hutchinson M. R., Northcutt A. L., Hiranita T., Wang X., Lewis S. S., Thomas J., van Steeg K., Kopajtic T. A., Loram L. C., Sfregola C., Galer E., Miles N. E., Bland S. T., Amat J., Rozeske R. R., Maslanik T., Chapman T. R., Strand K. A., Fleshner M., Bachtell R. K., Somogyi A. A., Yin H., Katz J. L., Rice K. C., Maier S. F., Watkins L. R. (2012) Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J. Neurosci. 32, 11187\u201311200", "ArticleIdList": ["PMC3454463", "22895704"]}, {"Citation": "Wang X., Grace P. M., Pham M. N., Cheng K., Strand K. A., Smith C., Li J., Watkins L. R., Yin H. (2013) Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. FASEB J. 27, 2713\u20132722", "ArticleIdList": ["PMC3688759", "23568774"]}, {"Citation": "O\u2019Neill L. A., Bowie A. G. (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353\u2013364", "ArticleIdList": ["17457343"]}, {"Citation": "Jerala R. (2007) Structural biology of the LPS recognition. Int. J. Med. Microbiol. 297, 353\u2013363", "ArticleIdList": ["17481951"]}, {"Citation": "Zhang T. S., Peng Y. H., Wang X. H. (2016) Drug discovery for treating drug addiction by targeting glia. Prog. Pharm. Sci. 39, 56\u201361"}, {"Citation": "Xiaozheng Z., Tianshu Z., Fengchao C., Yunqi L., Yinghua P., Xiaohui W. (2016) Toll-like receptor 4 small molecule modulators. Chin. J. of Appl. Chem. 33, 876\u2013886"}, {"Citation": "Wang X., Cochran T. A., Hutchinson M. R., Yin H., Watkins L. R. (2014) Drug addiction. In Microglia in Health and Disease (Tremblay M.-\u00c8., and Sierra A., eds.), pp. 299\u2013317, Springer, New York"}, {"Citation": "Watkins L. R., Hutchinson M. R., Rice K. C., Maier S. F. (2009) The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 30, 581\u2013591", "ArticleIdList": ["PMC2783351", "19762094"]}, {"Citation": "Lewis S. S., Hutchinson M. R., Rezvani N., Loram L. C., Zhang Y., Maier S. F., Rice K. C., Watkins L. R. (2010) Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience 165, 569\u2013583", "ArticleIdList": ["PMC2795035", "19833175"]}, {"Citation": "Lacagnina M. J., Watkins L. R., Grace P. M. (2018) Toll-like receptors and their role in persistent pain. Pharmacol. Ther. 184, 145\u2013158", "ArticleIdList": ["PMC5858962", "28987324"]}, {"Citation": "Peri F., Piazza M. (2012) Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol. Adv. 30, 251\u2013260", "ArticleIdList": ["21664961"]}, {"Citation": "Coller J. K., Hutchinson M. R. (2012) Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol. Ther. 134, 219\u2013245", "ArticleIdList": ["22316499"]}, {"Citation": "Wang Z., Chen G., Chen L., Liu X., Fu W., Zhang Y., Li C., Liang G., Cai Y. (2015) Insights into the binding mode of curcumin to MD-2: studies from molecular docking, molecular dynamics simulations and experimental assessments. Mol. Biosyst. 11, 1933\u20131938", "ArticleIdList": ["25923908"]}, {"Citation": "Fu W., Chen L., Wang Z., Zhao C., Chen G., Liu X., Dai Y., Cai Y., Li C., Zhou J., Liang G. (2016) Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2. Drug Des. Devel. Ther. 10, 455\u2013463", "ArticleIdList": ["PMC4737557", "26869767"]}, {"Citation": "Selfridge B. R., Wang X., Zhang Y., Yin H., Grace P. M., Watkins L. R., Jacobson A. E., Rice K. C. (2015) Structure-activity relationships of (+)-naltrexone-inspired Toll-like receptor 4 (TLR4) antagonists. J. Med. Chem. 58, 5038\u20135052", "ArticleIdList": ["PMC4634939", "26010811"]}, {"Citation": "Zhang X., Cui F., Chen H., Zhang T., Yang K., Wang Y., Jiang Z., Rice K. C., Watkins L. R., Hutchinson M. R., Li Y., Peng Y., Wang X. (2018) Dissecting the innate immune recognition of opioid inactive isomer (+)-naltrexone derived Toll-like receptor 4 (TLR4) antagonists. J. Chem. Inf. Model. 58, 816\u2013825", "ArticleIdList": ["PMC6700752", "29518316"]}, {"Citation": "Wang X., Zhang Y., Peng Y., Hutchinson M. R., Rice K. C., Yin H., Watkins L. R. (2016) Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Br. J. Pharmacol. 173, 856\u2013869", "ArticleIdList": ["PMC4761092", "26603732"]}, {"Citation": "Northcutt A. L., Hutchinson M. R., Wang X., Baratta M. V., Hiranita T., Cochran T. A., Pomrenze M. B., Galer E. L., Kopajtic T. A., Li C. M., Amat J., Larson G., Cooper D. C., Huang Y., O\u2019Neill C. E., Yin H., Zahniser N. R., Katz J. L., Rice K. C., Maier S. F., Bachtell R. K., Watkins L. R. (2015) DAT isn\u2019t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Mol. Psychiatry 20, 1525\u20131537", "ArticleIdList": ["PMC4523496", "25644383"]}, {"Citation": "Park B. S., Song D. H., Kim H. M., Choi B. S., Lee H., Lee J. O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191\u20131195", "ArticleIdList": ["19252480"]}, {"Citation": "Portoghese P. S., Nagase H., Lipkowski A. W., Larson D. L., Takemori A. E. (1988) Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. J. Med. Chem. 31, 836\u2013841", "ArticleIdList": ["2832604"]}, {"Citation": "Portoghese P. S., Nagase H., Takemori A. E. (1988) Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine. J. Med. Chem. 31, 1344\u20131347", "ArticleIdList": ["2838632"]}, {"Citation": "Ohto U., Fukase K., Miyake K., Shimizu T. (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc. Natl. Acad. Sci. USA 109, 7421\u20137426", "ArticleIdList": ["PMC3358893", "22532668"]}, {"Citation": "Sastry G. M., Adzhigirey M., Day T., Annabhimoju R., Sherman W. (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221\u2013234", "ArticleIdList": ["23579614"]}, {"Citation": "Roy D., Todd K., John M. (2009) GaussView, Version 5, Semichem Inc., Shawnee Mission, KS"}, {"Citation": "Becke A. D. (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys. Rev. A Gen. Phys. 38, 3098\u20133100", "ArticleIdList": ["9900728"]}, {"Citation": "Lee C., Yang W., Parr R. G. (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B Condens. Matter 37, 785\u2013789", "ArticleIdList": ["9944570"]}, {"Citation": "Miehlich B., Savin A., Stoll H., Preuss H. (1989) Results obtained with the correlation energy density functionals of Becke and Lee, Yang and Parr. Chem. Phys. Lett. 157, 200\u2013206"}, {"Citation": "Trott O., Olson A. J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Baxter J. (1981) Local optima avoidance in depot location. J. Oper. Res. Soc. 32, 815\u2013819"}, {"Citation": "Blum C., Aguilera M. J. B., Roli A., Sampels M. (2008) Hybrid Metaheuristics: An Emerging Approach to Optimization, Springer, Berlin:"}, {"Citation": "Phillips J. C., Braun R., Wang W., Gumbart J., Tajkhorshid E., Villa E., Chipot C., Skeel R. D., Kal\u00e9 L., Schulten K. (2005) Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781\u20131802", "ArticleIdList": ["PMC2486339", "16222654"]}, {"Citation": "Duan Y., Wu C., Chowdhury S., Lee M. C., Xiong G., Zhang W., Yang R., Cieplak P., Luo R., Lee T., Caldwell J., Wang J., Kollman P. (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999\u20132012", "ArticleIdList": ["14531054"]}, {"Citation": "Wang J., Wolf R. M., Caldwell J. W., Kollman P. A., Case D. A. (2004) Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174", "ArticleIdList": ["15116359"]}, {"Citation": "Dupradeau F. Y., Pigache A., Zaffran T., Savineau C., Lelong R., Grivel N., Lelong D., Rosanski W., Cieplak P. (2010) The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. Phys. Chem. Chem. Phys. 12, 7821\u20137839", "ArticleIdList": ["PMC2918240", "20574571"]}, {"Citation": "Ryckaert J.-P., Ciccotti G., Berendsen H. J. C. (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327\u2013341"}, {"Citation": "Darden T., York D., Pedersen L. (1993) Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092"}, {"Citation": "Feller S. E., Zhang Y. H., Pastor R. W., Brooks B. R. (1995) Constant pressure molecular dynamics simulation: the Langevin piston method. J. Chem. Phys. 103, 4613\u20134621"}, {"Citation": "Massova I., Kollman P. A. (2000) Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect. Drug Discov. Des. 18, 113\u2013135"}, {"Citation": "Sun H., Li Y., Tian S., Xu L., Hou T. (2014) Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys. Chem. Chem. Phys. 16, 16719\u201316729", "ArticleIdList": ["24999761"]}, {"Citation": "Genheden S., Ryde U. (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov. 10, 449\u2013461", "ArticleIdList": ["PMC4487606", "25835573"]}, {"Citation": "Spackov\u00e1 N., Cheatham T. E., III, Ryj\u00e1cek F., Lankas F., Van Meervelt L., Hobza P., Sponer J. (2003) Molecular dynamics simulations and thermodynamics analysis of DNA-drug complexes. Minor groove binding between 4\u2032,6-diamidino-2-phenylindole and DNA duplexes in solution. J. Am. Chem. Soc. 125, 1759\u20131769", "ArticleIdList": ["12580601"]}, {"Citation": "Torrie G. M., Valleau J. P. (1974) Monte Carlo free energy estimates using non-Boltzmann sampling: application to the sub-critical Lennard-Jones fluid. Chem. Phys. Lett. 28, 578\u2013581"}, {"Citation": "Kim H. M., Park B. S., Kim J. I., Kim S. E., Lee J., Oh S. C., Enkhbayar P., Matsushima N., Lee H., Yoo O. J., Lee J. O. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906\u2013917", "ArticleIdList": ["17803912"]}, {"Citation": "Kumar S., Bouzida D., Swendsen R. H., Kollman P. A., Rosenberg J. M. (1992) The weighted histogram analysis method for free-energy calculations on biomolecules. 1. The method. J. Comput. Chem. 13, 1011\u20131021"}, {"Citation": "Manning T. J., Jr., Sontheimer H. (1999) Recording of intracellular Ca2+, Cl-, pH and membrane potential in cultured astrocytes using a fluorescence plate reader. J. Neurosci. Methods 91, 73\u201381", "ArticleIdList": ["10522826"]}, {"Citation": "Hargreaves K., Dubner R., Brown F., Flores C., Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77\u201388", "ArticleIdList": ["3340425"]}, {"Citation": "Bachtell R., Hutchinson M. R., Wang X., Rice K. C., Maier S. F., Watkins L. R. (2015) Targeting the toll of drug abuse: the translational potential of Toll-like receptor 4. CNS Neurol. Disord. Drug Targets 14, 692\u2013699", "ArticleIdList": ["PMC5548122", "26022268"]}, {"Citation": "Neumann H., Wekerle H. (2013) Brain microglia: watchdogs with pedigree. Nat. Neurosci. 16, 253\u2013255", "ArticleIdList": ["23434975"]}, {"Citation": "Henn A., Lund S., Hedtj\u00e4rn M., Schrattenholz A., P\u00f6rzgen P., Leist M. (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26, 83\u201394", "ArticleIdList": ["19565166"]}, {"Citation": "Gorina R., Font-Nieves M., M\u00e1rquez-Kisinousky L., Santalucia T., Planas A. M. (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF\u03baB signaling, MAPK, and Jak1/Stat1 pathways. Glia 59, 242\u2013255", "ArticleIdList": ["21125645"]}, {"Citation": "Theberge F. R., Li X., Kambhampati S., Pickens C. L., St Laurent R., Bossert J. M., Baumann M. H., Hutchinson M. R., Rice K. C., Watkins L. R., Shaham Y. (2013) Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving. Biol. Psychiatry 73, 729\u2013737", "ArticleIdList": ["PMC3615146", "23384483"]}, {"Citation": "Shah M., Anwar M. A., Yesudhas D., Krishnan J., Choi S. (2016) A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: an in silico approach. Sci. Rep. 6, 39271", "ArticleIdList": ["PMC5159903", "27982096"]}, {"Citation": "Hutchinson M. R., Zhang Y., Shridhar M., Evans J. H., Buchanan M. M., Zhao T. X., Slivka P. F., Coats B. D., Rezvani N., Wieseler J., Hughes T. S., Landgraf K. E., Chan S., Fong S., Phipps S., Falke J. J., Leinwand L. A., Maier S. F., Yin H., Rice K. C., Watkins L. R. (2010) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 24, 83\u201395", "ArticleIdList": ["PMC2788078", "19679181"]}, {"Citation": "Ikeda H., Kiritoshi T., Murase K. (2012) Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat. Mol. Pain 8, 43", "ArticleIdList": ["PMC3418174", "22703840"]}]}], "History": [{"Year": "2019", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31162938", "PMC6988860", "10.1096/fj.201900173RRR"]}}]}